Endocrine List 2 Flashcards
Describe Graves disease
Hyperthyroidism due to pathological stimulation of TSH receptor
Autoimmune induced excess production of TH
Clinical presentation of Graves disease
Rapid Heart beat
Tremor
Diffuse palpable goiter with audible bruit
Eye problems: bulging outwards and lid retraction
Graves’ opthalmopathy
Graves dermopathy (rare)
Thyroid acropachy (clubbing, finger and toe swelling)
Pathophysiology of Graves disease
TSH receptor stimulating antibodies (TSHR-Ab) recognise and bind to the TSH receptors in thyroid
- > stimulates thyroid hormone production T4 and T3
- > thyroxine (T4) receptors in the pituitary gland are activated by excess hormone
- > reduced release of TSH in a negative feedback look
- > Very high levels of circulating thyroid hormones, with a low TSH
- > as well as excess secretion of thyroid hormones, also results in hyperplasia of thyroid follicular cells resulting in hyperthyroidism and diffuse goitre
Aetiology/Risk factors of Graves disease
Some genetic element - association with HLA-B8, DR3 & DR2.
Smoking
Stress
High iodine intake
E.coli and other gram-NEGATIVE organisms contain TSH-binding sites so may initiate pathogenesis via ‘molecular mimicry’
Autoimmune disease.
Associated with other autoimmune diseases, such as Vitiligo (pale patches on skin), Addison’s, type 1 DM, pernicious anaemia and myasthenia gravis.
Epidemiology of Graves disease
Most common cause of hyperthyroidism (2/3 of cases)
More common in females
Typically presents at 40-60 years (appear earlier if maternal family history)
Diagnostic of Graves disease
High T3 and T4
Lower TSH than normal
Mild neutropenia
*TSH receptor stimulating antibodies (TSHR-Ab) raised
Treatment of Graves disease
Antithyroid drugs (Carbimazole or Propylthiouracil) with either dose titration or ‘block and replace’.
Thyroidectomy.
Radioactive iodine.
Beta blockers
Complications of Graves disease
Thyroid storm: treat with Propylthiouracil
Also similar to auto-antigen, can result in retro-orbital inflammation - graves opthalmopathy
Describe Hashimotos thyroiditis
Hypothyroidism due to aggressive destruction of thyroid cells
(autoimmune hypothyroidism)
Clinical Presentation of Hashimotos thyroiditis
Thyroid gland may enlarge rapidly, occasionally with dyspnoea or dysphagia from pressure on the neck
Hypothyroidism: Fatigue, cold intolerance, slowed movement, decreased sweating
Pathophysiology of Hashimotos thyroiditis
Aggressive destruction of thyroid cells by various cell and antibody mediated immune processes.
Antibodies bind and block TSH receptors -> inadequate thyroid hormone production and secretion.
Thyroid peroxidase is essential hormone for production and storage of thyroid hormone: Thyroid peroxidase antibodies (TPO-Ab) are present in high titres
Aetiology of Hashimotos thyroiditis
What are triggers?
Unknown.
Autoimmune.
Some genetic element.
Triggers; iodine, infection, smoking and possibly stress
Epidemiology of Hashimotos thyroiditis
12-20 times more frequent in women.
Most common cause of goitrous hypothyroidism.
Diagnostic tests of Hashimotos thyroiditis
TSH levels, usually raised in hypothyroidism.
Thyroid antibodies.
Treatment of Hashimotos thyroiditis
Levothyroxine therapy (may shrink the goitre) Thyroid hormone replacement Resection of obstructive goitre.
Complications of Hashimotos thyroiditis
Hyperlipidemia
Define Sequelae
condition which is the consequence of a previous disease or injury
Sequelae of Hashimotos Thyroiditis
Hashimotos encephalopathy
Describe hypothyroidism
Reduced action/levels of thyroid hormone
Types of hypothyroidism (briefly explain each)
Primary - disease associated with thyroid
Secondary - disease associated with pituitary or hypothalamus
Transient - disease associated with treatment withdrawal
Clinical presentation of Hypothyroidism
(same for all 3 types)
Insidious onset.
Tiredness, lethargy, intolerance of cold, goitre, slowing of intellectual activity, constipation, deep hoarse voice.
Puffy face, hands and feet.
Menorrhagia, weight gain, myalgia, dementia, myxoedema (accumulation of mucopolysaccharide in SC tissue)
Pathophysiology of Primary Hypothyroidism
Aggressive destruction of thyroid cells by various cell and antibody mediated immune processes.
Antibodies bind and block TSH receptors
-> inadequate thyroid hormone production and secretion
Pathophysiology of Secondary Hypothyroidism
Reduced release or production of TSH by pituitary or hypothalamus (respectively)
-> reduced T3 and T4 release
Pathophysiology of Transient Hypothyroidism
The thyroid overcompensates until it can reestablish correct concentrations of Thyroid hormone
Aetiology of Primary Hypothyroidism
Autoimmune hypothyroidism (Hashimoto’s), iodine deficiency, congenital defects
Aetiology of Secondary Hypothyroidism
Isolated TSH deficiency, hypopituitarism (due to neoplasm, infection), hypothalamic disorders (neoplasms, trauma)
Aetiology of Transient Hypothyroidism
Withdrawal of thyroid suppressive therapy such as radioactive iodine
Epidemiology of Primary Hypothyroidism
More common in Japan
Diagnostic tests of Hypothyroidism
Thyroid Function Tests (TFTs)
Serum free T4 levels low
Thyroid antibodies may be present
Blood tests:
Raised serum aspartate transferase levels from muscle and/or liver
Increase serum creatinine kinase levels associated with myopathy
Hypercholesterolaemia
Hyponatraemia due to an increase in ADH and impaired free water clearance
Treatment of Primary Hypothyroidism
Thyroid hormone replacement (Levothyroxine) - dose is titrated until TSH normalises
Resection of obstructive goitre
Treatment of Secondary Hypothyroidism
Thyroid hormone replacement (Levothyroxine). Treat underlying cause
Treatment of Transient Hypothyroidism
Remits on its own
Complications of Hypothyroidism
Myxoedema coma (20-50% mortality) Reduced level of consciousness, seizures, cardiac failure, hypothermia and hypothyroidism
severe hypothyroidism/reduced T4
Types of thyroid cancer/malignancies
Papillary (named for papillae among its cells on microscopy)
Follicular
Anaplastic (one of most aggressive cancers in human)
Lymphoma
Medullary
What types of thyroid cancers fit this clinical presentation:
Usually asymptomatic thyroid nodule (usually hard and fixed). Possibly enlarged lymph nodes on examination.
Papillary
Follicular
Anaplastic
Clinical presentation of Lymphoma (thyroid malignancy)
Rapidly growing mass in the neck
Clinical presentation of Medullary cancer (thyroid malignancy)
Diarrhoea
Flushing episodes (similar to Carcinoid syndrome)
Itching
Pathophysiology of papillary thyroid cancer
Tends to spread locally in neck, compressing the trachea
Pathophysiology of follicular thyroid cancer
May infiltrate neck, but greater propensity to metastasise to lung and bones relative to papillary
Pathophysiology of anaplastic thyroid cancer
Follicular cells of the thyroid, but does not retain original cell features like iodine uptake or synthesis of thyroglobulin
Pathophysiology of lymphoma thyroid cancer
Almost always non-hodgkins lymphoma
Pathophysiology of medullary thyroid cancer
Parafollicular calcitonin-producing C cells. Produce large amounts of peptide such as calcitonin
Aetiology of medullary thyroid cancer
Often familial
Epidemiology of papillary thyroid cancer
70% of thyroid cancer.
Young people.
Three times more common in women.
Epidemiology of follicular thyroid cancer
20% of thyroid cancer.
Middle age.
Tends to be in areas of low iodine.
Epidemiology of anaplastic thyroid cancer
<5% of thyroid cancer
Epidemiology of lymphoma thyroid cancer
2% of thyroid cancer.
Often associated with Hashimoto’s thyroiditis.
Epidemiology of medullary thyroid cancer
5% of thyroid cancer.
More sporadic than hereditary.
Diagnostic tests of thyroid cancer
Fine needle aspiration.
Differences: Medullary; elevated serum calcitonin.
Treatment of medullary thyroid cancer
Total thyroidectomy and prophylactic central lymph node dissection
Which thyroid cancers would you treat via:
External radiotherapy to provide relief (largely palliative)
Anaplastic
Lymphoma
Treatment of Papillary thyroid cancer
Total thyroidectomy -> ablative radioactive iodine
same for follicular thyroid cancer
Treatment of Follicular thyroid cancer
Total thyroidectomy -> ablative radioactive iodine
same for papillary thyroid cancer
Describe Cushing’s syndrome
Persistently and inappropriately elevated circulating glucocorticoid (cortisol)
This is attributed to inappropriate ACTH secretion from the pituitary (due to tumour)
Clinical presentation of Cushing’s syndrome
(truncal) Obesity (fat distribution central, buffalo hump)
plethoric complexion
Rounded ‘moon face’, thin skin, bruising, striae, hypertension, pathological fractures
Acne
Cataracts, Ulcers, Skin striae, Hyperglycarmia/hypertension, Increased infection, Necrosis, Glucosuria/gonal dysfunction
Pathophysiology of Cushing’s syndrome
Excess cortisol can either result from excess ACTH which in turn stimulates excess cortisol release or from neoplasms in the adrenals which in turn stimulate the zona reticularis to release more cortisol.
Excess can also result from ingesting excess glucocorticoid itself e.g. PREDNISOLONE
Many features due to protein-catabolic effects of cortisol; thin skin, easy bruising, striae. Excessive alcohol consumption can mimic the clinical and biochemical signs (Pseudo-Cushings’s), but resolves on alcohol recession
Aetiology of Cushing’s syndrome
ACTH (adrenocortiotropic hormone) dependent disease:
Cushings disease - Bilateral adrenal hyperplasia from an ACTH-secreting pituitary adenoma (benign).
Ectopic Cushings syndrome - paraneoplastic syndrome (tumour elsewhere in body producing ACTH - especially small cell lung cancer and carcinoid tumours)
ACTH treatment e.g. for asthma
ACTH independent:
Excess oral steroids! (iatrogenic)
Adrenal adenomas,
adrenal carcinomas, excess glucocorticoid administration (most common) e.g. Prednisolone
Epidemiology of Cushing’s syndrome
10/1,000,000.
Higher incidence in diabetes.
2/3 cases are Cushing’s disease.
Most common cause is oral steroids i.e. glucocorticoid therapy.
Spontaneous endogenous causes are rare, but 80% due to raised ACTH, with pituitary adenoma being the most common cause
Diagnostic tests of Cushing’s syndrome
Confirm raised cortisol: 48 hour low-dose dexamethasone: Fail to suppress cortisol is diagnostic of Cushings.
Urinary free cortisol over 24hrs (normal levels mean Cushings unlikely).
Late night salivary cortisol. Establishing cause: CT and MRI of renal and pituitary
NOT random plasma cortisol test as cortisol levels change through day (stress, illness, morning)
Treatment of Cushing’s syndrome
Stop steroids if iatrogenic
Transphenoidal removal of pituitary adenoma if Cushings disease
Adrenalectomy or Radiotherapy if Adrenal Adenoma
Ectopic ACTH: Surgical removal of tumour if location known
Cortisol synthesis inhibition: metyrapone, ketoconazole
Complications of Cushing’s syndrome
Hypertension, obesity, death
Describe Acromegaly
Overgrowth of all organ systems due to excess GH
Increased production of growth hormone occurring in adults after fusion of the epiphyseal plates
Clinical Presentation of Acromegaly
Slow onset (old photos). Larger hands/feet. Large tongue, prognathism, interdental separation, spade-like hands.
If (acromegaly) tumour arises before fusion of epiphyseal plates (children bones), what condition can result instead/like acromegaly
Gigantism
worse as don’t stop growing as bones not developed
Pathophysiology of Acromegaly
GH acts directly on tissues such as liver, muscle bone or fat, as well as indirectly through induction of insulin like growth factor. Excess causes uncontrolled growth of organ systems.
Very slow insidious onset over many years
Aetiology of Acromegaly
Usually excessive GH secretion by a pituitary tumour. Other GH releasing tumours possible (hypothalamus, specific lung cancers).
Mainly pituitary adenoma
Epidemiology of Acromegaly
3 per million per year
Average 40 yrs.
Same in male and females
Diagnostic tests of Acromegaly
Glucose tolerance test: IGF-1 raised. GH raised.
MRI the pituitary fossa for adenomas
Treatment of Acromegaly
Transsphenoidal resection surgery. Dopamine agonists (cabergoline), somatostatin analogues (octreotide) and GH receptor antagonists (pegvisomant)
Complications of Acromegaly
Hypertension, diabetes.
Untreated adenoma can impact the optic chiasm -> blindness
Colorectal cancer
Describe Conn’s syndrome
Primary hyperaldosteronism
High aldosterone levels independent of Renin-Angiotensin system
Clinical presentation of Conn’s syndrome
Hypertension (possibly low urine output) Hypokalemic: -Constipation -Weakness and cramps -Paraesthesia -Polyuria and polydipsia
What is secondary hyperaldosteronism
Hyperaldosteronism due to high renin levels
What is another name for Primary Hyperaldosteronism
Conn’s syndrome
Pathophysiology of Conn’s syndrome
Aldosterone causes an exchange of transport of sodium and potassium in the distal renal tubule.
Therefore, hyperaldosteronism causes increased reabsorption of sodium (and water) and excretion of potassium
Aetiology of Conn’s syndrome
Adrenal adenoma secreting aldosterone in Conn’s syndrome (or possibly bilateral adrenal hyperplasia)
Diagnostic tests of Conn’s syndrome
Plasma Aldosterone (increased) and Renin (decreased)
U and E
Adrenal CT
ECG
Treatment of Conn’s syndrome
Adenoma: Surgical removal (laparoscopic adrenalectomy)
Hyperplasia: aldosterone antagonist or potassium-sparing diuretic (spironolactone)
Describe Adrenal Insufficiency
Hypoadrenalism
due to destruction or reduced stimulation of adrenal cortex
What are types of Adrenal Insufficiency and describe the difference between the two
Primary insufficiency - Destruction of adrenal cortex
Secondary insufficiency - Reduction of adrenal cortex stimulation
What is another name for Primary Adrenal Insufficiency
Addison’s disease
What is key difference in clinical presentation between Primary and Secondary adrenal insufficiency
Primary - Hyperpigmentation
Secondary - no pigmentation
*Why does Primary Adrenal Insufficiency result in hyper pigmentation but Secondary AI does not?
Primary:
Destruction of adrenal cortex -> Less cortical products. Excess ACTH -> stimulates melanocytes -> hyper pigmentation
Secondary:
Reduction of adrenal cortex stimulation -> Less cortical products. Low ACTH -> less melanocytes stimulation -> no pigmentation
Clinical presentation of Addison’s disease (primary adrenal insufficiency)
Thin, tanned, tired and tearful.
HYPER-pigmentation.
Insidious. Non-specific symptoms; lethargy, depression, anorexia, weight loss, weakness and fatigue. Postural hypotension. GI: N+V, abdominal pain
Clinical presentation of Secondary Adrenal Insufficiency
Insidious. Non-specific symptoms; lethargy, depression, anorexia, weight loss, weakness and fatigue. Postural hypotension. Thin, tanned, tired and tearful.
NO pigmentation
Pathophysiology of Addison’s disease (primary adrenal insufficiency)
Autoimmune destruction of the entirety adrenal cortex. Associated with other autoimmune conditions.
Loss of cortex -> reduction in ability to produce Cortisol and/or Aldosterone.
Excess ACTH stimulates melanocytes -> pigmentation.
Pathophysiology of Secondary Adrenal Insufficiency
Inadequate pituitary or hypothalamic stimulation of the adrenal glands. No pigmentation, since ACTH levels are low.
Aetiology of Addison’s disease (primary adrenal insufficiency)
Organ specific autoantibodies in 90% of cases. Rarely; adrenal gland tuberculosis, surgical removal or haemorrhage
Addisons is commonest cause in the UK of adrenal insufficiency, TB is most common cause WORLDWIDE
Aetiology of Secondary Adrenal Insufficiency
Hypothalamic-pituitary disease or from long term steroid therapy leading to hypothalamic-pituitary-adrenal suppression.
Iatrogenic
Epidemiology of Addison’s disease (primary adrenal insufficiency)
1/10,000
Addisons is commonest cause in the UK of adrenal insufficiency, TB is most common cause WORLDWIDE
Epidemiology of Secondary Adrenal Insufficiency
200/1,000,000
Diagnostic tests of Addison’s disease (primary adrenal insufficiency)
Sodium reduction, potassium elevation due to low aldosterone.
Short ACTH stimulation test (Give ACTH (synacthen), then measure cortisol level; in Addison, cortisol remains low after giving ACTH).
test for 21-hydroxylase adrenal autoabs (+ve in 80% Addisons)
Diagnostic tests of Secondary Adrenal Insufficiency
Long ACTH test (synacthen test) to distinguish from primary: ACTH raised in primary, lowered in secondary
Treatment of Addison’s disease (primary adrenal insufficiency)
Cortisol hormone replacement - glucocorticoid (hydrocotisone)
Aldosterone replacement via mineralocorticoid (fludrocortisone) - this also helps treat postural hypotension
Treatment of Secondary Adrenal Insufficiency
Hormone replacement (just hydrocortisone). If from steroid therapy; remove steroids very slowly
Complications of Addison’s
Adrenal crisis (patients present with shock, severe hypotension, lost a lot of fluid via vomitting and reduced reabsorption of Na+ -> treat with fluid, hydrocortisone) Reduced QOL
Describe Adrenal Hyperplasia
Defective enzymes mediating the production of adrenal cortex products.
Low cortisol, maybe low aldosterone, high androgen
Clinical presentation of Adrenal Hyperplasia
In severe forms; salt loss. Female: Ambiguous genitalia with common urogenital sinus. Male: no signs at birth, bar subtle hyperpigmentation and possible penile enlargement.
Pathophysiology of Adrenal Hyperplasia
Defective 21-hydroxylase -> disruption of cortisol biosynthesis. This causes cortisol deficiency, with or without aldosterone deficiency and androgen excess. In severe forms, aldosterone deficiency -> salt loss
Aetiology of Adrenal Hyperplasia
Genetic 21-hydroxylase deficiency is the cause of about 95% of cases.
Diagnostic tests of Adrenal Hyperplasia
Serum 17-hydroxyprogesterone (precursor to cortisol) levels: high
Treatment of Adrenal Hyperplasia
Glucocorticoids: Hydrocortisone
Mineralocorticoids: Control electrolytes
If salt loss: Sodium chloride supplement
Describe Diabetes Insipidus
Hyposecretion or insensitivity to ADH
Types of Diabetes Insipidus and their difference
Cranial - Hyposecretion
Nephrogenic - Insensitivity
Clinical presentation of Diabetes Insipidus
Polyuria
Compensatory polydipsia
Dehydration
Pathophysiology of Cranial Diabetes Insipidus
Disease of the hypothalamus, where ADH is produced -> Insufficient ADH production. Interestingly, damage to the Posterior Pituitary gland, does not lead to ADH deficiency, as it can still ‘leak’ out.
Pathophysiology of Nephrogenic Diabetes Insipidus
Depends on the aetiology. Can be due to disruption of the channels, damage to the kidney -> *Lack of response to ADH
Aetiology of Cranial Diabetes Insipidus
trauma, pituitary tumour
Neurosurgery,, infiltrative disease, idiopathic Genetic: Mutations in the ADH gene
Aetiology of Nephrogenic Diabetes Insipidus
Hypokalaemia, hypercalcaemia, drugs, renal tubular acidosis, sickle cell, prolonged polyuria, chronic kidney disease Genetic: Mutation in ADH receptor
Epidemiology of Diabetes Insipidus
1/25,000
Diagnostic tests of Diabetes Insipidus
Water deprivation test: Confirm DI
Restrict fluid, measure osmolarity (urine osmolarity low means DI)
Desmospressin (ADH analogues) to differentiate between cranial and nephrogenic
Urine volume: Confirm polyuria.
U&Es (urine and electrolytes): Confirm not a more common cause of polyuria
MRI of hypothalamus: Confirm CDI
Treatment of Cranial Diabetes Insipidus
Desmopressin.
Mild cases: thiazide diuretics, carbamazepine and chlorpropramide to sensitise the renal tubules to endogenous vasopressin.
Treatment of Nephrogenic Diabetes Insipidus
Bendroflumethizide (diuretics) -> cause more Na+ excretion
NSAIDs - reduce GFR
Treatment of the cause.
Describe syndrome of inappropriate ADH secretion
Continued ADH secretion in spite of plasma hypotonicity and normal plasma volume
(opposite of DI)
Clinical presentation of syndrome of inappropriate ADH secretion
Nausea, anorexia, confusion
Concentrated urine
Irritability and headache with mild dilutional hyponatraemia.
Fits and coma with severe hyponatraemia.
Pathophysiology of syndrome of inappropriate ADH secretion
Ectopic (abnormal) production increases the amount of ADH produced, beyond mechanisms of control.
Aetiology of syndrome of inappropriate ADH secretion
Disordered hypothalamic-pituitary secretion, or ectopic production of ADH.
Neurological: Tumour, trauma, infection
Pulmonary: Lung small cell cancer (common), mesothelioma, cystic fibrosis
Drugs an CNS disorders also
Diagnostic tests of syndrome of inappropriate ADH secretion
(FBC)
Measure urine and plasma osmolarity
Treatment of syndrome of inappropriate ADH secretion
Route: IV
Treat underlying cause
Restrict fluid
Vasopressin receptor antagonists (vaptans)
Describe Hyperparathyroidism
Excessive secretion of PTH
Types of hyperparathyroidism (describe each briefly)
Primary - One parathyroid gland produces excess PTH
Secondary - Increased secretion of PTH to compensate hypocalcemia
Tertiary - Autonomous secretion of PTH due to CKD (chronic kidney disease)
Clinical presentation of primary hyperparathyroidism
70-80% asymptomatic. Bone pain, renal calculi, nausea, neuropsychiatric (Bones, stones, abdominal groans and psychic moans)
Bone resorption causes pain, fracture, osteoporosis. Leads to hypercalcaemia (weak, tired, depressed, thirsty, renal stones)
Hypertension
Clinical presentation of secondary hyperparathyroidism
Kidney disease, with skeletal or cardiovascular complications
Clinical presentation of tertiary hyperparathyroidism
Bone pain, renal calculi, nausea, neuropsychiatric (Bones, stones, abdominal groans and psychic moans)
Pathophysiology of primary hyperparathyroidism
Adenoma or hyperplasia provides additional secretive tissue to provide excess PTH
Pathophysiology of secondary hyperparathyroidism
Parathyroid gland becomes hyperplastic in response to chronic hypocalcemia
Pathophysiology of tertiary hyperparathyroidism
Glands become autonomous, producing excess of PTH even after the correction of calcium deficiency
Aetiology of primary hyperparathyroidism
Single parathyroid adenoma or hyperplasia
80% = solitary adenoma
20% = parathyroid hyperplasia
(parathyroid cancer rare)